Valvular Heart Disease in the Elderly

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry

Abstract

Degenerative aetiology predominates in valvular heart disease. This review summarises the main group of valvular diseases with the main focus on their management. Aortic stenosis increases in frequency with age, and the important causes are the degenerative calcifying valves, congenital abnormalities and rheumatic in origin. About half the patients with AS die suddenly. The key symptoms indicating intervention are angina, exertional syncope and heart failure, but the ideal management of severe aortic stenosis with left ventricular dysfunction is controversial. Transcatheter aortic valve replacement (TAVR) is an option for patients with high or very high risk for surgical aortic valve replacement. Aortic valve replacement is indicated in severe AR who are symptomatic and in patients with severe AR who are asymptomatic but with left ventricular systolic dysfunction. Surgery is indicated in patients with severe MR with symptoms, and the factors influencing the timing of intervention are the symptoms, left ventricular ejection fraction, atrial fibrillation and pulmonary hypertension. Surgery in mitral stenosis depends on the symptoms right ventricular function, and pulmonary artery pressure.

Keywords

Aortic stenosis Aortic regurgitation Mitral regurgitation Mitral stenosis Transcatheter aortic valve replacement Percutaneous mitral balloon valvuloplasty 

References

  1. 1.
    Lung B, Baron G, Butchart EG, Delahaye F, Gohike-Barwolf C, Levang OW, et al. A prospective study of patients with valvular heart disease in eUope. TheEuro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231–1243.CrossRefGoogle Scholar
  2. 2.
    Malhotra A. The changing burden of valvular heart disease. Bitish Cardiovascular Society. http://www.bcs.com/pages/news_full.asp?News ID=19792059.
  3. 3.
    Novaro GM,Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffn BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205–2209.CrossRefPubMedGoogle Scholar
  4. 4.
    McKilop GM, Stewart DA, Burns JM, Ballantyne D. Doppler echocardiography in elderly patients with ejection systolic murmurs. Postgrad Med J. 1991;67(794):1059–61.CrossRefGoogle Scholar
  5. 5.
    Aronow WC, Kronzon I. Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiography and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients. Am J Cardiol. 1991;67(8):776–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiene JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–634.CrossRefPubMedGoogle Scholar
  7. 7.
    Curtin RJ, Griffin BP. Valvular heart disease: etiology. ACP Medicine Online. Website: www.medscape.com/viewarticle/535378
  8. 8.
    Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: From bench to the bedside-emerging clinical and cellular concepts. Heart. 2003;89:801–805.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Freeman RV, Otto CM. Spectrum of calcific aortic valve disease. Circulation. 2005;111:3316–3326.CrossRefPubMedGoogle Scholar
  10. 10.
    Otto CM. Aortic stenosis: Clinical evaluation and optimal timing of surgery. Cardiol Clin. 1998;16(3):353–73.CrossRefPubMedGoogle Scholar
  11. 11.
    Carabello BA. Evaluation and management of patients with aortic stenosis. Circulation. 2002;105:1746–1750.CrossRefPubMedGoogle Scholar
  12. 12.
    Sciomer S, Badagliacca R, Vizza CD, Fedele F. Echocardiography in aortic stenosis: new insights into challenging senarios. Ital Heart J. Suppl 2004;5(6):457–65.PubMedGoogle Scholar
  13. 13.
    Manning WJ. Asymptomatic Aortic stenosis in the Elderly: A clinical review. JAMA. 2013;310(4):1490–1497.CrossRefPubMedGoogle Scholar
  14. 14.
    Lung B, Cachier A, Baron G, Messika-Zeiton D, Delahaye F, Tomos P, et al. Decreasing mortality in elderly patients with severe aortic stenosis: why so many are denied surgery? Eur Heart J. 2005;26(24):2714–2720.CrossRefGoogle Scholar
  15. 15.
    Wong MCG, Clark DJ, Horrigan MCG, Grube E, Matalanis G, Farouque HM. Advances in percutaneous treatment for adult valvular heart disease. Int Med J. 2009;39:465–474.CrossRefGoogle Scholar
  16. 16.
    Otto CM, Mickel MC, Kennedy EL, Alderman EL,Bashore TM, Block PC, et al Three-year outcome after ballon aortic valvuloplasty: insights into thre prognosis of valvular aortic stenosis. Circulation. 1994;89:642–50.CrossRefPubMedGoogle Scholar
  17. 17.
    Sawhney N, Hassankham A, Greenberg BH. Calcific aortic stenosis in the elderly “A brief overview. Am J Geriatr Cardiol. 2013;12(3):http://www.medscape.com/viewarticle/456334_4 retrieved 7 January 2014.
  18. 18.
    Letac B, Cribier A, Koning R, Lefebvre F. Aortic stenosis in the elderly patients aged 80 or older. Treatment by percutaneous balloon valvuloplasty in a seruies of 92 cases. Circulation. 1989;80:1514–1520.CrossRefPubMedGoogle Scholar
  19. 19.
    Osnabrugge RLJ, Mylotte D, Head SJ, Van Mieghem M, Nkomo VT, LeReun CM, et al. Disease prevalence and number of candidates for transcatheter aortic valve replacement :b A meta-analysis and modelling study. J Am Coll Cardiol. 2013;62(11):1002–1012.CrossRefPubMedGoogle Scholar
  20. 20.
    Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovasculkar Disease in the young, and the Coucil on Clinical Cardiology, council on Cardiovasculsr Surgery and Anaesthesia and the Quality of Care and Outcomes Research Interdisciplinary Working Group, Circulation. 2007;116:1736–1754.CrossRefPubMedGoogle Scholar
  21. 21.
    Enriquz-Sarano M,Tajik AJ. Aortic regurgitation. NEJM. 2004;351:1539–1546.CrossRefGoogle Scholar
  22. 22.
    Bekeredjian R, Grayburn PA. Valvular heart disease. Aortic regurgitation. Circulation. 2005;112:125–134.CrossRefPubMedGoogle Scholar
  23. 23.
    Heidenreich PA, Schnittger I, Hancock L, Atwood JE. A systolic murmur is a common presentation of aortic regurgitation determined by echocardiography. Clin Cardiol. 2004;278:502–506.CrossRefGoogle Scholar
  24. 24.
    Nkomo VT,Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart disease: a population – based study. Lancet. 2006;368:1005–1011.CrossRefPubMedGoogle Scholar
  25. 25.
    Sutton MG, Gorman LC. Surgery for asymptomatic severe aortic regurgitation in the elderly. Early surgery or wait and watch? Circulation. 2006;114:258–260.CrossRefPubMedGoogle Scholar
  26. 26.
    ACC/AHA. Pocket Guidelines, June 2006.Google Scholar
  27. 27.
    Chikwe J, Goldstone AB, Passage J, Anyanwu AC, Seeburger J, Castillo JG, et al. A propensity score-adjusted retrospective comparison of early and mid-term results of mitral repair versus replacemernt in octogenarians. Eur Heart J. 2011;32:618–626.CrossRefPubMedGoogle Scholar
  28. 28.
    Alfieri O, Maisano F. Mitral valve syrgery in the elderly: new insights and unanswered questions. Eur Heart J. 2011;32:535–536.CrossRefPubMedGoogle Scholar
  29. 29.
    Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smallng R, et al. , Percutaneous repair with the MitraClip system: Safety and midterm durability in initial EVEREST ( Endovascular Valve Edge-to-Edge Repair Study) cohort. J Am Coll Cardiol. 2009;5(8):686–94.CrossRefGoogle Scholar
  30. 30.
    Tamburino C, Ussia GP, Maisano F,Capodanno D, La Carna G, Scandura R, et al. Percutaneous mitral valve repair with the MitraClip system:acute results from a real world setting. Eur Heart J. 2010;3(11):1382–9.CrossRefGoogle Scholar
  31. 31.
    Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis wuth cardiovascular mortality and morbidity in the elderly. NEJM. 199;341:142–147.Google Scholar
  32. 32.
    Taramasso M, Pozzoli A, Buzzatii, Allieri O. Assessing operative risk and benefit in elderly patients with heart valve disease. Eur Heart J. 2013;34(36):2788–2791.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations